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 Background: Muscle atrophy is the loss of muscle mass or activity and is a common 
phenomenon in aging, long duration bed rest, neuromuscular diseases as well as in 
spaceflight. Whilst several muscle degradation pathways such as the Ubiquitin-
proteasome pathway, autophagy and calpain mediated pathway have been identified, no 
cure has been found yet. Mitochondrial dysfunction has been connected with muscle 
atrophy in several studies, including aging, diabetes, Duchenne muscular dystrophy 
(DMD) and spaceflight however the exact molecular pathway connecting the two is still 
unclear. Most of the muscle degradation pathways are activated as a result in 
intracellular cues but recent evidence about the importance of the integrin attachment 
complex for maintaining muscle cell integrity in C. elegans implicates the importance of 
the extracellular matrix (ECM) in muscle cell. Since there is no evidence for a clear role 
of ECM in muscle atrophy, this study explores the direct role of mitochondrial 
dysfunction as an intramuscular signal for muscle dystrophy through ECM degradation.  
Objectives: In our quest for finding novel pathway of muscle atrophy we laid out our 
objectives as follows: 
• To understand how mitochondrial dysfunction can lead to muscle atrophy 
• To find if the ECM is one of the key factors connecting mitochondrial dysfunction 
with muscle atrophy 
Results: I found that treatment of wild-type C. elegans with Antimycin A (an Electron 
Transport Chain inhibitor) leads to paralysis as well as muscle damage. The most 
common kind of damage observed was that of wavy myofilaments which were sometimes 
accompanied with breakage in myofilament structure (Figure 1). Surprisingly, the wavy 
myofilament phenotype was closely associated with EMB-9 (Collagen IV in C. elegans) 
degradation in Antimycin A treated wild-type worms. Similar wavy myofilaments were 
observed when the EMB-9 TS mutant (g34) was kept under restrictive temperature. On 
the other hand, overexpression of EMB-9 could suppress the motility defect as well as 
muscle damage. EMB-9 degradation is mediated by the matrix metalloproteinases 
(MMPs). MMP on the other hand, are activated by Furin. Furin is a calcium dependent 
proprotein convertase which undergoes structural modification and activation upon 
binding with calcium ion. I found that treatment with a Furin inhibitor or a MMP 
inhibitor could also rescue the muscle damage mediated by Antimycin A. I also observed 
an increase in muscle cytoplasmic Ca2+ concentration upon Antimycin A treatment, 
monitored through GCaMP3.35 imaging system. To confirm if Ca2+ overload is 
responsible for Antimycin A mediated muscle damage, I analyzed the effect of Antimycin 
A on two calcium channel mutant strains. I found that both unc-68 and egl-19 mutant 
animals could suppress the muscle damage observed upon Antimycin A treatment. 
Duchenne muscular dystrophy (DMD) is a genetic disorder caused by mutation in 
dystrophin gene. Mitochondrial dysfunction and dysregulated calcium pathway have 
been implicated as possible causes of the disease. I found that unc-68 RNAi could 
suppress muscle damage in the dys-1 (DMD model of C. elegans) mutant worms, as 
shown by some researchers previously. I also found that MMP inhibitor and Furin 
inhibitor could significantly reduce the muscle damage in the dys-1 mutant worms as 
well. These results show that the MMP>Furin>ECM degradation axis is not only 
responsible for muscle damage in the Antimycin A model, but is also one of the key 
pathways activated in DMD. 
Conclusion: This leads us to conclude that, in the case of mitochondrial dysfunction, as 
a first step there is an upregulation of intracellular calcium. The calcium overload 
activated the MMP>Furin>ECM axis, which leads to muscle atrophy (Figure 2). 
Preventing collagen degradation by inhibition of unc-68, MMP and Furin can delay 
muscle damage and keep the muscle structure intact for a longer time. Hence, we have 
established that ECM stability is crucial to prevent and delay muscle damage, and 
mitochondrial dysfunction is a key intramuscular signal of ECM degradation, which 
serves as a novel and important pathway of muscle atrophy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Mitochondrial dysfunction mediated by Antimycin A results in paralysis and 
muscle cell damage in C. elegans. Age synchronized wild-type animals were grown to 
young adulthood at 20°C. Adult animals were then treated with 0, 2, 4 and 10 µM 
Antimycin A for 36 h, after which: (A) the animals were analyzed with a platinum wire 
pick for movement defects/paralysis. Values indicate the percentage of animals paralyzed 
in each group. 20 animals were analyzed for each experiment with three independent 
repetitions (n = 60 animals). A significant increase in paralysis was observed in 4 µM 
(p<0.01) and 10 µM (p<0.05) concentrations. Number of worms from left to right: 59, 60, 
60, and 59. (B) Muscle structure was visualized using Rhodamine Phalloidin after 36 h 
treatment with Antimycin A. Values indicate the average percentage of damaged muscle 
per animal. A significant increase in damaged muscle cells was observed in 2 µM (p<0.01), 
4 µM (p<0.01) and 10 µM (p<0.01) Antimycin A. Number of muscle cells from left to right: 
63, 54, 74, and 85. (C) Representative images of myofilament alignment in normal and 
Antimycin A-damaged muscle cells. The damaged muscle displays wavy myofilaments 
and large gaps in between, compared to normal muscle cells. Scale bar: 10 µM. 
 
  
  
 
 
 
 
 
 
 
 
 
 
Figure 2: Collagen is essential for regulation of muscle cell activity and structure.  
In the case of mitochondrial dysfunction, as a first step there is an upregulation of 
intracellular calcium (possibly due to SERCA loss of function) which leads to furin 
activation. Furin then further activates MMPs which degrade collagen, an important 
ECM component. This then leads to muscle dystrophy. Preventing collagen degradation 
by inhibition of RYR, MMP and Furin can delay muscle damage and keep the muscle 
structure intact for a longer time. 
 
